4AB:XETRA AbbVie Inc

EUR 166.22 +0.50 ( +0.30)%
Icon

AbbVie Inc (4AB:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 166.22

+0.50 (+0.30)%

EUR 309.83B

1.04K

N/A

N/A

Icon

4AB:XETRA

AbbVie Inc (EUR)
COMMON STOCK | XETRA
EUR 166.22
+0.50 ( +0.30)%
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 309.83B

N/A

EUR 166.22

AbbVie Inc (4AB:XETRA) Stock Forecast

N/A

Based on the AbbVie Inc stock forecast from 0 analysts, the average analyst target price for AbbVie Inc is not available over the next 12 months. AbbVie Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AbbVie Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, AbbVie Inc’s stock price was EUR 166.22. AbbVie Inc’s stock price has changed by +0.52% over the past week, +1.94% over the past month and +16.65% over the last year.

No recent analyst target price found for AbbVie Inc
No recent average analyst rating found for AbbVie Inc

Company Overview AbbVie Inc

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Cro...Read More

https://www.abbvie.com

1 North Waukegan Road, North Chicago, IL, United States, 60064-6400

50,000

December

EUR

Germany

Adjusted Closing Price for AbbVie Inc (4AB:XETRA)

Loading...

Unadjusted Closing Price for AbbVie Inc (4AB:XETRA)

Loading...

Share Trading Volume for AbbVie Inc Shares

Loading...

Compare Performance of AbbVie Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 4AB:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To AbbVie Inc (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LLY:XETRA
Eli Lilly and Company -6.50 (-0.86%) EUR713.88B 90.93 61.62

Frequently Asked Questions About AbbVie Inc (4AB:XETRA) Stock

Stock Target Advisor's fundamental analysis for AbbVie Inc's stock is Neutral.

4AB:XETRA stock's dividend yield is 3.50%. Our analysis grades 4AB:XETRA stock's dividend yield at D+. This means that 4AB:XETRA stock's dividend yield is above 69% of the stocks in the Drug Manufacturers - General sector in the XETRA exchange. Based on this 4AB:XETRA may be a average dividend stock for its sector.

Unfortunately we do not have enough data on 4AB:XETRA's stock to indicate what its average analyst target is.

4AB:XETRA stock's Price/Earning ratio is 64.01. Our analysis grades 4AB:XETRA stock's Price / Earning ratio at F. This means that 4AB:XETRA stock's Price/Earning ratio is above 79% of the stocks in the Drug Manufacturers - General sector in the XETRA exchange. Based on this 4AB:XETRA may be a overvalued for its sector.

The last closing price of 4AB:XETRA's stock was EUR 166.22.

The most recent market capitalization for 4AB:XETRA is EUR 309.83B.

Unfortunately we do not have enough analyst data on 4AB:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains AbbVie Inc's stock.

As per our most recent records AbbVie Inc has 50,000 Employees.

AbbVie Inc's registered address is 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400. You can get more information about it from AbbVie Inc's website at https://www.abbvie.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About AbbVie Inc (4AB:XETRA) Stock

Stock Target Advisor's fundamental analysis for AbbVie Inc's stock is Neutral.

4AB:XETRA stock's dividend yield is 3.50%. Our analysis grades 4AB:XETRA stock's dividend yield at D+. This means that 4AB:XETRA stock's dividend yield is above 69% of the stocks in the Drug Manufacturers - General sector in the XETRA exchange. Based on this 4AB:XETRA may be a average dividend stock for its sector.

Unfortunately we do not have enough data on 4AB:XETRA's stock to indicate what its average analyst target is.

4AB:XETRA stock's Price/Earning ratio is 64.01. Our analysis grades 4AB:XETRA stock's Price / Earning ratio at F. This means that 4AB:XETRA stock's Price/Earning ratio is above 79% of the stocks in the Drug Manufacturers - General sector in the XETRA exchange. Based on this 4AB:XETRA may be a overvalued for its sector.

The last closing price of 4AB:XETRA's stock was EUR 166.22.

The most recent market capitalization for 4AB:XETRA is EUR 309.83B.

Unfortunately we do not have enough analyst data on 4AB:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains AbbVie Inc's stock.

As per our most recent records AbbVie Inc has 50,000 Employees.

AbbVie Inc's registered address is 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400. You can get more information about it from AbbVie Inc's website at https://www.abbvie.com.
Loading...